Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement.

Stute, Petra; Spyropoulou, Areti; Karageorgiou, Vasilios; Cano, Antonio; Bitzer, Johannes; Ceausu, Iuliana; Chedraui, Peter; Durmusoglu, Fatih; Erkkola, Risto; Goulis, Dimitrios G; Lindén Hirschberg, Angelica; Kiesel, Ludwig; Lopes, Patrice; Pines, Amos; Rees, Margaret; van Trotsenburg, Mick; Zervas, Iannis; Lambrinoudaki, Irene (2020). Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement. Maturitas, 131, pp. 91-101. Elsevier 10.1016/j.maturitas.2019.11.002

[img] Text
31740049.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (831kB) | Request a copy

INTRODUCTION

Globally, the total number of people with depression exceeds 300 million, and the incidence rate is 70 % greater in women. The perimenopause is considered to be a time of increased risk for the development of depressive symptoms and major depressive episodes.

AIM

The aim of this position statement is to provide a comprehensive model of care for the management of depressive symptoms in perimenopausal and early menopausal women, including diagnosis, treatment and follow-up. The model integrates the care provided by all those involved in the management of mild or moderate depression in midlife women.

MATERIALS AND METHODS

Literature review and consensus of expert opinion.

SUMMARY RECOMMENDATIONS

Awareness of depressive symptoms, early detection, standardized diagnostic procedures, personalized treatment and a suitable follow-up schedule need to be integrated into healthcare systems worldwide. Recommended treatment comprises antidepressants, psychosocial therapies and lifestyle changes. Alternative and complementary therapies, although widely used, may help with depression, but a stronger evidence base is needed. Although not approved for this indication, menopausal hormone therapy may improve depressive symptoms in peri- but not in postmenopausal women, especially in those with vasomotor symptoms.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology

UniBE Contributor:

Stute, Petra

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0378-5122

Publisher:

Elsevier

Language:

English

Submitter:

Monika Zehr

Date Deposited:

30 Dec 2019 11:03

Last Modified:

30 Dec 2019 11:03

Publisher DOI:

10.1016/j.maturitas.2019.11.002

PubMed ID:

31740049

Uncontrolled Keywords:

Depression EMAS Early menopause Menopausal hormone therapy Menopausal transition Model of care Perimenopause

BORIS DOI:

10.7892/boris.136521

URI:

https://boris.unibe.ch/id/eprint/136521

Actions (login required)

Edit item Edit item
Provide Feedback